newest glp-1 drugs The Revolution: From Diabetes and Obesity to Alzheimer's and PCOS Swiss Re says GLP-1 drugs
Description
Clinical evidence also suggests potential advantages in wound healing
Shaughness M, Acs D, Brabazon F, Hockenbury N, Byrnes KR
S., Chauhan M
GLP-1 adjudicated volume grew at an unprecedented rate after the release of Mounjaro, though it lagged the growth of written demand, meaning that as more GLP-1 prescriptions were written, a greater proportion of prescriptions were also rejected or abandoned
Lancet (2018) 392(10157):151929
